Although the drug zoledronic acid slows bone loss in osteoporosis patients, it also boosts levels of a biomarker that stops bone formation, according to a recent study.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/E...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/E...